THORN RUN PARTNERS

Lobbying for THE BIOSIMILARS FORUM · Non-profit Organization

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $100,000.00 income · posted Apr 17, 2025

Lobbying activity 2

Medicare/Medicaid

Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation.

Health Issues

Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.